Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lanling Pharmaceutical
Changzhou, Jiangsu, China
- Ownership
- Private
- Development stage
- Other
01
Overview
Lanling Pharmaceutical is an established pharmaceutical company focused on the production of active pharmaceutical ingredients (APIs) and finished dosage forms, primarily serving the generic drug market in China and internationally with a focus on gastrointestinal and cardiovascular health.
- Therapeutic areas
- EndocrinologyCardiovascularInfectious DiseasesGastroenterology
- Modalities
- Small molecule
- Industry
- Biotech
Beyond the preview
Go deeper on Lanling Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Lanling Pharmaceutical.